A detailed history of Ogorek Anthony Joseph transactions in Abbott Laboratories stock. As of the latest transaction made, Ogorek Anthony Joseph holds 1,972 shares of ABT stock, worth $232,222. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,972
Previous 1,968 0.2%
Holding current value
$232,222
Previous $204,000 9.8%
% of portfolio
0.08%
Previous 0.07%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$100.07 - $118.13 $400 - $472
4 Added 0.2%
1,972 $224,000
Q2 2024

Aug 08, 2024

BUY
$100.73 - $112.44 $302 - $337
3 Added 0.15%
1,968 $204,000
Q1 2023

May 03, 2023

BUY
$96.86 - $114.01 $48,430 - $57,005
500 Added 34.13%
1,965 $198,000
Q1 2018

Apr 18, 2018

BUY
$56.27 - $63.62 $6,302 - $7,125
112 Added 8.28%
1,465 $87,000
Q4 2017

Jan 22, 2018

BUY
$53.68 - $57.47 $10,306 - $11,034
192 Added 16.54%
1,353 $77,000
Q3 2017

Oct 25, 2017

BUY
$48.06 - $53.64 $55,797 - $62,276
1,161
1,161 $61,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ogorek Anthony Joseph Portfolio

Follow Ogorek Anthony Joseph and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ogorek Anthony Joseph , based on Form 13F filings with the SEC.

News

Stay updated on Ogorek Anthony Joseph with notifications on news.